Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business
Axcan Pharma Inc. - Strategic Analysis Review

Axcan Pharma Inc. - Strategic Analysis Review - new market report released


Print article Print article
© companiesandmarkets.com

companiesandmarkets.com
companiesandmarkets.com
2010-04-14 14:45:02 - Axcan Pharma Inc. - Strategic Analysis Review - a new market research report on companiesandmarkets.com

Axcan Pharma Inc. - Strategic Analysis Review

Summary

Axcan Pharma Inc. - Strategic Analysis Review´ is an in-depth business and strategic analysis of “Axcan Pharma Inc.”. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

Axcan Pharma Inc. (Axcan) is a privately held specialty pharmaceutical company engaged in development and commercialization of drugs for the treatment of gastrointestinal ailments. It has more than 40 products and dosages in the market for the treatment of inflammatory bowel disease, cholestatic liver diseases, irritable bowel syndrome, and complications

 

 

related to pancreatic insufficiency. It also conducts research and development of advanced stage products acquired from third parties. The company has its operations in North America and Europe with its headquarters located in Quebec, Canada. In February 2008, Axcan Pharma, Inc.

And More inside the report…

Recent Developments

Jul 22, 2009: NewBridge Signs License, Supply Agreement With Axcan

Scope

- Provides key company information for business intelligence needs
- The company’s strengths and weaknesses and areas of development or decline are analyzed. Strategic and operational factors are considered.
- The opportunities open to the company are considered and its growth potential assessed. Competitive and/or technological threats are highlighted.
- The report contains critical company information – business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.

Reasons to buy

- A quick “one-stop-shop” to understand the company.
- Enhance business/sales activities by understanding customers’ businesses better.
- Get detailed information and strategic analysis on companies operating in your industry.
- Identify prospective partners and suppliers – with key data on their businesses and locations.
- Capitalize on competitors’ weaknesses and target the market opportunities available to them.
- Scout for potential acquisition targets, with detailed insight into the companies’ strategic, and operational performance.

Click for report details: www.companiesandmarkets.com/Summary-Company-Profile/axcan-pharma ..


Author:
Mike King
e-mail
Web: www.companiesandmarkets.com
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser